INFI - Infinity Pharmaceuticals EPS misses by $0.01 misses on revenue October, 30 2019 04:10 PM Infinity Pharmaceuticals Inc. Infinity Pharmaceuticals (NASDAQ:INFI): Q3 GAAP EPS of -$0.20 misses by $0.01.More news on: Infinity Pharmaceuticals, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...